AUSTRALIAN JOURNAL OF BIOMEDICAL RESEARCH
Review Article
Aug 16, 2025 230 99

Hospital-Acquired Infections in the Age of Antimicrobial Resistance and Smart Surveillance

Olabisi Lawal 1 * ,
Idris Olumide Orenolu 2,
Morayo Anne Ajobiewe 3,
Kwesi Akonu Adom Mensah Forson 4,
Ujunwa Favour Agu 5,
Moses Emmanuel Fidelix 6,
Frances Chinaechekwa Madugba 7,
Lenin Ifeanyi Obi 8
1 Department of Medical Laboratory Science,University of Benin, Benin City, Nigeria 2 Infection Prevention and Control, Saskatchewan Health Authority, Saskatchewan, Canada 3 Nursing Program, Faculty of Health Sciences, University of Lethbridge, Lethbridge, Alberta, Canada4 Department of Biology, University of Virginia, Charlottesville, USA 5 Department of Nursing Sciences, Faculty of Allied Health Sciences, Enugu State University of Science and Technology, Enugu State, Nigeria6 Department of Medical Laboratory Science, University of Benin, Benin City, Nigeria7 Department of Pharmaceutical Microbiology, Faculty of Pharmacy, University of Benin, Benin City, Nigeria 8 Department of Nursing Science, Ladoke Akintola University of Technology, Ogbomoso, Nigeria * Corresponding Author
Australian Journal of Biomedical Research, 1(1), 2025, aubm002, https://doi.org/10.63946/aubiomed/16759
Publication date: Aug 16, 2025
Full Text (PDF)

ABSTRACT

Hospital-acquired infections (HAIs) continue to be one of the biggest problems for modern healthcare systems, and the problem is getting worse because antimicrobial resistance (AMR) is on the rise. Antibiotics that used to work are quickly losing their effectiveness, which is giving rise to highly adaptable bacteria in clinical settings and turning routine procedures into high-risk situations. This publication examines the intersection of healthcare-associated infections (HAIs) and antimicrobial resistance (AMR) within the framework of smart surveillance—digital, data-driven systems engineered to identify, predict, and disrupt the spread of infections in real time. We examine the historical development of infection surveillance, analyze the epidemiological burden and resistance mechanisms contributing to a covert pandemic, and assess emerging technologies such as electronic health record integration, machine-learning analytics, genomic sequencing, and Internet of Things (IoT) sensor networks. These new ideas give us new ways to prevent infections before they happen, but they also bring up difficult moral, legal, and social problems about privacy, fairness, and governance. We contend that intelligent surveillance should be integrated into comprehensive infection prevention frameworks and antimicrobial stewardship initiatives to establish resilient hospitals. By combining predictive analytics with basic IPC procedures, ethical monitoring, and giving workers more autonomy, healthcare organizations may turn passive surveillance into active defense. In the end, winning the war against HAIs will depend not just on cutting-edge technology, but also on how it is used with care, honesty, and openness.

KEYWORDS

Hospital-acquired infections Antimicrobial resistance Smart surveillance Predictive analytics Infection prevention and control.

CITATION (Vancouver)

Lawal O, Orenolu IO, Ajobiewe MA, Mensah Forson KAA, Agu UF, Fidelix ME, et al. Hospital-Acquired Infections in the Age of Antimicrobial Resistance and Smart Surveillance. Australian Journal of Biomedical Research. 2025;1(1):aubm002. https://doi.org/10.63946/aubiomed/16759
APA
Lawal, O., Orenolu, I. O., Ajobiewe, M. A., Mensah Forson, K. A. A., Agu, U. F., Fidelix, M. E., Madugba, F. C., & Obi, L. I. (2025). Hospital-Acquired Infections in the Age of Antimicrobial Resistance and Smart Surveillance. Australian Journal of Biomedical Research, 1(1), aubm002. https://doi.org/10.63946/aubiomed/16759
Harvard
Lawal, O., Orenolu, I. O., Ajobiewe, M. A., Mensah Forson, K. A. A., Agu, U. F., Fidelix, M. E., . . . Obi, L. I. (2025). Hospital-Acquired Infections in the Age of Antimicrobial Resistance and Smart Surveillance. Australian Journal of Biomedical Research, 1(1), aubm002. https://doi.org/10.63946/aubiomed/16759
AMA
Lawal O, Orenolu IO, Ajobiewe MA, et al. Hospital-Acquired Infections in the Age of Antimicrobial Resistance and Smart Surveillance. Australian Journal of Biomedical Research. 2025;1(1), aubm002. https://doi.org/10.63946/aubiomed/16759
Chicago
Lawal, Olabisi, Idris Olumide Orenolu, Morayo Anne Ajobiewe, Kwesi Akonu Adom Mensah Forson, Ujunwa Favour Agu, Moses Emmanuel Fidelix, Frances Chinaechekwa Madugba, and Lenin Ifeanyi Obi. "Hospital-Acquired Infections in the Age of Antimicrobial Resistance and Smart Surveillance". Australian Journal of Biomedical Research 2025 1 no. 1 (2025): aubm002. https://doi.org/10.63946/aubiomed/16759
MLA
Lawal, Olabisi et al. "Hospital-Acquired Infections in the Age of Antimicrobial Resistance and Smart Surveillance". Australian Journal of Biomedical Research, vol. 1, no. 1, 2025, aubm002. https://doi.org/10.63946/aubiomed/16759

REFERENCES

  1. Okonkwo PI, Okafor KC, Garbal JH, Kwaghal BS, Boluwatito B. Hospital Acquired Infections (HAIs) Prevention Practices Among Medical Students in a Teaching Hospital in Jos, Plateau State, Nigeria. Eur J Med Health Sci. 2024;6(2):14-20. DOI: 10.24018/ejmed.2024.6.2.1917
  2. Salam MdA, Al-Amin MdY, Salam MT, Pawar JS, Akhter N, Rabaan AA, et al. Antimicrobial Resistance: A Growing Serious Threat for Global Public Health. Healthcare (Basel). 2023;11(13):1946. DOI: 10.3390/healthcare11131946
  3. Yeung AWK, Torkamani A, Butte AJ, Glicksberg BS, Schuller B, Rodriguez B, et al. The promise of digital healthcare technologies. Front Public Health. 2023;11:1196596. DOI: 10.3389/fpubh.2023.1196596
  4. Kolagari S. Increasing Importance of Florence Nightingale’s Theory During the 21st-Century Pandemic Period. Florence Nightingale J Nurs. 2023;31(3):215-6. DOI: 10.5152/FNJN.2023.23040
  5. Poczai P, Karvalics LZ. The little-known history of cleanliness and the forgotten pioneers of handwashing. Front Public Health. 2022;10:979464. DOI: 10.3389/fpubh.2022.979464
  6. Quiros-Roldan E, Sottini A, Natali PG, Imberti L. The Impact of Immune System Aging on Infectious Diseases. Microorganisms. 2024;12(4):775. DOI: 10.3390/microorganisms12040775
  7. World Health Organization. The burden of health care-associated infection worldwide. [Internet]. 2025 [cited 2025 Aug 5]. Available from: https://www.who.int/news-room/feature-stories/detail/the-burden-of-health-care-associated-infection-worldwide
  8. Abubakar U, Amir O, Rodríguez-Baño J. Healthcare-associated infections in Africa: a systematic review and meta-analysis of point prevalence studies. J Pharm Policy Pract. 2022;15(1):99. DOI: 10.1186/s40545-022-00498-w
  9. Li P, Li Y, Zhang Y, Bao J, Yuan R, Lan H, et al. Economic burden attributable to healthcare-associated infections in tertiary public hospitals of Central China: a multi-centre case-control study. Epidemiol Infect. 2022;150:e155. DOI: 10.1017/S0950268822001310
  10. Harun MdGD, Anwar MMU, Sumon SA, Hassan MZ, Haque T, Mah-E-Muneer S, et al. Infection prevention and control in tertiary care hospitals of Bangladesh: results from WHO infection prevention and control assessment framework (IPCAF). Antimicrob Resist Infect Control. 2022;11:125. DOI: 10.1186/s13756-022-01165-0
  11. Calfee DP. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci, and other Gram-positives in healthcare. Curr Opin Infect Dis. 2012;25(4):385-94. DOI: 10.1097/QCO.0b013e3283553441
  12. Jump RL. Clostridium difficile infection in older adults. Aging Health. 2013;9(4):403-14. DOI: 10.2217/ahe.13.37
  13. Bouhrour N, Nibbering PH, Bendali F. Medical Device-Associated Biofilm Infections and Multidrug-Resistant Pathogens. Pathogens. 2024;13(5):393. DOI: 10.3390/pathogens13050393
  14. Murray S, Gale F, Adams D, Dalton L. A scoping review of the conceptualisations of food justice. Public Health Nutr. 2023;26(4):725-37. DOI: 10.1017/S1368980022002620
  15. Seid M, Bayou B, Aklilu A, Tadesse D, Manilal A, Zakir A, et al. Antimicrobial resistance patterns of WHO priority pathogens at general hospital in Southern Ethiopia during the COVID-19 pandemic, with particular reference to ESKAPE-group isolates of surgical site infections. BMC Microbiol. 2025;25:84. DOI: 10.1186/s12866-025-03054-9
  16. Tao S, Chen H, Li N, Wang T, Liang W. The Spread of Antibiotic Resistance Genes In Vivo Model. Can J Infect Dis Med Microbiol. 2022;2022:3348695. DOI: 10.1155/2022/3348695
  17. Yamin D, Uskoković V, Wakil AM, Goni MD, Shamsuddin SH, Mustafa FH, et al. Current and Future Technologies for the Detection of Antibiotic-Resistant Bacteria. Diagnostics (Basel). 2023;13(20):3246. DOI: 10.3390/diagnostics13203246
  18. Galgano M, Pellegrini F, Catalano E, Capozzi L, Del Sambro L, Sposato A, et al. Acquired Bacterial Resistance to Antibiotics and Resistance Genes: From Past to Future. Antibiotics. 2025;14(3):222. DOI: 10.3390/antibiotics14030222
  19. Skender K, Machowska A, Khare S, Singh V, Lundborg CS, Sharma M. Antibiotic prescribing practices, perceived constraints, and views on antimicrobial resistance among general and orthopedic surgeons in central India. Sci Rep. 2025;15:25099. DOI: 10.1038/s41598-025-74525-8
  20. Muteeb G, Rehman MT, Shahwan M, Aatif M. Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on Drug Development: A Narrative Review. Pharmaceuticals. 2023;16(11):1615. DOI: 10.3390/ph16111615
  21. Kumar NR, Balraj TA, Kempegowda SN, Prashant A. Multidrug-Resistant Sepsis: A Critical Healthcare Challenge. Antibiotics (Basel). 2024;13(1):46. DOI: 10.3390/antibiotics13010046
  22. Husna A, Rahman MdM, Badruzzaman ATM, Sikder MH, Islam MR, Rahman MdT, et al. Extended-Spectrum β-Lactamases (ESBL): Challenges and Opportunities. Biomedicines. 2023;11(11):2937. DOI: 10.3390/biomedicines11112937
  23. Lodise TP, Nguyen ST, Margiotta C, Cai B. Clinical burden of Acinetobacter baumannii, including carbapenem-resistant A. baumannii, in hospitalized adult patients in the USA between 2018 and 2022. BMC Infect Dis. 2025;25(1):549. DOI: 10.1186/s12879-025-12345-2
  24. Shenoy ES, Branch-Elliman W. Automating surveillance for healthcare-associated infections: Rationale and current realities (Part I/III). Antimicrob Steward Healthc Epidemiol. 2023;3(1):e25. DOI: 10.1017/ash.2023.156
  25. Negro-Calduch E, Azzopardi-Muscat N, Krishnamurthy RS, Novillo-Ortiz D. Technological progress in electronic health record system optimization: Systematic review of systematic literature reviews. Int J Med Inform. 2021;152:104507. DOI: 10.1016/j.ijmedinf.2021.104507
  26. Hudu SA, Alshrari AS, Abu-Shoura EJI, Osman A, Jimoh AO. A Critical Review of the Prospect of Integrating Artificial Intelligence in Infectious Disease Diagnosis and Prognosis. Interdiscip Perspect Infect Dis. 2025;2025:6816002. DOI: 10.1155/2025/6816002
  27. Vashisht V, Vashisht A, Mondal AK, Farmaha J, Alptekin A, Singh H, et al. Genomics for Emerging Pathogen Identification and Monitoring: Prospects and Obstacles. BioMedInformatics. 2023;3(4):1145-77. DOI: 10.3390/biomedinformatics3040069
  28. Wu J, Lin Y, Lee S, Chen C, Cheng S, Cheng C, et al. IoT-Based Hand Hygiene Compliance Monitoring System and Validation of Its Effectiveness in Hospital Environments. Glob Chall. 2024;8(12):2400124. DOI: 10.1002/gch2.202400124
  29. Profetto L, Gherardelli M, Iadanza E. Radio Frequency Identification (RFID) in health care: where are we? A scoping review. Health Technol (Berl). 2022;12(5):879-91. DOI: 10.1007/s12553-022-00683-6
  30. Fox JM, Saunders NJ, Jerwood SH. Economic and health impact modelling of a whole genome sequencing-led intervention strategy for bacterial healthcare-associated infections for England and for the USA. Microb Genom. 2023;9(8):mgen001087. DOI: 10.1099/mgen.0.001087
  31. Shenoy ES, Branch-Elliman W. Automating surveillance for healthcare-associated infections: Rationale and current realities (Part I/III). Antimicrob Steward Healthc Epidemiol. 2023;3(1):e25. DOI: 10.1017/ash.2023.156
  32. Obama BM, Grant R, Harbarth S, Buetti N, Catho G. Digitalised measures for the prevention of central line-associated bloodstream infections: a scoping review. Antimicrob Resist Infect Control. 2025;14:45. DOI: 10.1186/s13756-025-00945-4
  33. Shenoy S, Jena A, Levinson C, Sharma V, Deepak P, Aswani-Omprakash T, et al. Inflammatory bowel disease in south Asia: a scoping review. Lancet Gastroenterol Hepatol. 2025;10(3):259-74. DOI: 10.1016/S2468-1253(24)00356-8
  34. Danchin A. Artificial intelligence-based prediction of pathogen emergence and evolution in the world of synthetic biology. Microb Biotechnol. 2024;17(10):e70014. DOI: 10.1111/1751-7915.14399
  35. Yamin D, Uskoković V, Wakil AM, Goni MD, Shamsuddin SH, Mustafa FH, et al. Current and Future Technologies for the Detection of Antibiotic-Resistant Bacteria. Diagnostics (Basel). 2023;13(20):3246. DOI: 10.3390/diagnostics13203246
  36. Arzilli G, De Vita E, Pasquale M, Carloni LM, Pellegrini M, Di Giacomo M, et al. Innovative Techniques for Infection Control and Surveillance in Hospital Settings and Long-Term Care Facilities: A Scoping Review. Antibiotics. 2024;13(1):77. DOI: 10.3390/antibiotics13010077
  37. Alhumaid S, Al Mutair A, Al Alawi Z, Alsuliman M, Ahmed GY, Rabaan AA, et al. Knowledge of infection prevention and control among healthcare workers and factors influencing compliance: a systematic review. Antimicrob Resist Infect Control. 2021;10:86. DOI: 10.1186/s13756-021-00957-0
  38. Wang C, Jiang W, Yang K, Yu D, Newn J, Sarsenbayeva Z, et al. Electronic Monitoring Systems for Hand Hygiene: Systematic Review of Technology. J Med Internet Res. 2021;23(11):e27880. DOI: 10.2196/27880
  39. Sathitakorn O, Jantarathaneewat K, Weber DJ, Apisarnthanarak P, Rutjanawech S, Apisarnthanarak A. Efficacy of Environmental Cleaning Protocol Featuring Real-Time Feedback with and without PX-UV in Reducing the Contamination of Gram-Negative Microorganisms on High-Touch Surfaces in Four Intensive Care Units in Thailand. Antibiotics (Basel). 2023;12(3):438. DOI: 10.3390/antibiotics12030438
  40. Seewald NJ. Adaptive Interventions for a Dynamic and Responsive Public Health Approach. Am J Public Health. 2023;113(1):37-9. DOI: 10.2105/AJPH.2022.307187
  41. Bhalla M, Aggarwal A, Fatima KH. Carbapenem-resistant bacteria on hand-held and hands-free electronic devices of healthcare workers and non-healthcare workers in Delhi, India. Infect Prev Pract. 2021;3(3):100162. DOI: 10.1016/j.infpip.2021.100162
  42. Khadse SN, Ugemuge S, Singh C. Impact of Antimicrobial Stewardship on Reducing Antimicrobial Resistance. Cureus. 2023;15(12):e49935. DOI: 10.7759/cureus.49935
  43. Intensive Care Society. State of the Art (SOA) 2023 Congress Abstracts. J Intensive Care Soc. 2023;24(2 Suppl):1-196. DOI: 10.1177/17511437231183900
  44. Junaid SB, Imam AA, Balogun AO, De Silva LC, Surakat YA, Kumar G, et al. Recent Advancements in Emerging Technologies for Healthcare Management Systems: A Survey. Healthcare (Basel). 2022;10(10):1940. DOI: 10.3390/healthcare10101940
  45. Cornistein W, Santonato D, Novau PA, Fabbro LG, Jorge MF, Malvicini MA, et al. Synergy between infection control and antimicrobial stewardship programs to control carbapenem-resistant Enterobacterales. Antimicrob Steward Healthc Epidemiol. 2023;3(1):e162. DOI: 10.1017/ash.2023.437
  46. Perez F, Villegas MV. The role of surveillance systems in confronting the global crisis of antibiotic-resistant bacteria. Curr Opin Infect Dis. 2015;28(4):375-83. DOI: 10.1097/QCO.0000000000000183
  47. Lawal OP, Egwuatu EC, Akanbi KO, Orobator ET, Eweje OZ, Omotayo EO, et al. Fighting Resistance With Data: Leveraging Digital Surveillance to Address Antibiotic Misuse in Nigeria. Path Sci. 2025;11(3):1009-17. DOI: 10.22178/pos.96-3
  48. Nazer LH, Zatarah R, Waldrip S, Ke JXC, Moukheiber M, Khanna AK, et al. Bias in artificial intelligence algorithms and recommendations for mitigation. PLOS Digit Health. 2023;2(6):e0000278. DOI: 10.1371/journal.pdig.0000278
  49. Zuhair V, Babar A, Ali R, Oduoye MO, Noor Z, Chris K, et al. Exploring the Impact of Artificial Intelligence on Global Health and Enhancing Healthcare in Developing Nations. J Prim Care Community Health. 2024;15:21501319241245847. DOI: 10.1177/21501319241245847
  50. Gong E, Wang H, Zhu W, Galea G, Xu J, Yan LL, et al. Bridging the digital divide to promote prevention and control of non-communicable diseases for all in China and beyond. BMJ. 2024;387:e076768. DOI: 10.1136/bmj-2023-076768
  51. Fukami T. Enhancing Healthcare Accountability for Administrators: Fostering Transparency for Patient Safety and Quality Enhancement. Cureus. 2024;16(8):e66007. DOI: 10.7759/cureus.66007
  52. Garcia R, Barnes S, Boukidjian R, Goss LK, Spencer M, Septimus EJ, et al. Recommendations for change in infection prevention programs and practice. Am J Infect Control. 2022;50(12):1281-95. DOI: 10.1016/j.ajic.2022.03.028
  53. Shehab N, Alschuler L, McILvenna S, Gonzaga Z, Laing A, deRoode D, et al. The National Healthcare Safety Network's digital quality measures: CDC's automated measures for surveillance of patient safety. J Am Med Inform Assoc. 2024;31(5):1199-205. DOI: 10.1093/jamia/ocae038
  54. Mader R, Damborg P, Amat JP, Bengtsson B, Bourély C, Broens EM, et al. Building the European Antimicrobial Resistance Surveillance network in veterinary medicine (EARS-Vet). Euro Surveill. 2021;26(4):2001359. DOI: 10.2807/1560-7917.ES.2021.26.4.2001359
  55. Feng Y, Kristensen SR, Lorgelly P, Meacock R, Núñez-Elvira A, Rodés-Sánchez M, et al. Pay-for-Performance incentives for specialised services in England: a mixed methods evaluation. Eur J Health Econ. 2024;25(5):857-76. DOI: 10.1007/s10198-023-01626-2
  56. Morency-Potvin P, Schwartz DN, Weinstein RA. Antimicrobial Stewardship: How the Microbiology Laboratory Can Right the Ship. Clin Microbiol Rev. 2017;30(1):381-407. DOI: 10.1128/CMR.00066-16
  57. Subrahmanya SVG, Shetty DK, Patil V, Hameed BMZ, Paul R, Smriti K, et al. The role of data science in healthcare advancements: applications, benefits, and future prospects. Ir J Med Sci. 2022;191(4):1473-83. DOI: 10.1007/s11845-021-02784-z
  58. Branda F, Scarpa F. Implications of Artificial Intelligence in Addressing Antimicrobial Resistance: Innovations, Global Challenges, and Healthcare's Future. Antibiotics (Basel). 2024;13(6):502. DOI: 10.3390/antibiotics13060502
  59. Li L, Back E, Lee S, Shipley R, Mapitse N, Elbe S, et al. Balancing Risks and Opportunities: Data-Empowered-Health Ecosystems. J Med Internet Res. 2025;27:e57237. DOI: 10.2196/57237
  60. Uwishema O, Masunga DS, Naisikye KM, Bhanji FG, Rapheal AJ, Mbwana R, et al. Impacts of environmental and climatic changes on future infectious diseases. Int J Surg. 2023;109(2):167-70. DOI: 10.1097/JS9.0000000000000231
  61. Łukasik M, Porębska A. Responsiveness and Adaptability of Healthcare Facilities in Emergency Scenarios: COVID-19 Experience. Int J Environ Res Public Health. 2022;19(2):675. DOI: 10.3390/ijerph19020675
  62. Lawal O, Elechi K, Adekunle F, Farinde O, Kolapo T, Igbokwe C, et al. A Review on Artificial Intelligence and Point-of-Care Diagnostics to Combat Antimicrobial Resistance in Resource-Limited Healthcare Settings like Nigeria: Review Article. J Pharm Insights Res. 2025;3(2):166-75. DOI: 10.53011/jpir.2025.3.2.25
  63. Lawal O, Oyebamiji HO, Kelenna IJ, Chioma FJ, Oyefeso E, Adeyemi BI, et al. A Review on Usage of Digital Health Literacy to Combat Antibiotic Misuse and Misinformation in Nigeria: Review Article. J Pharm Insights Res. 2025;3(2):258-69. DOI: 10.53011/jpir.2025.3.2.38

LICENSE

Creative Commons License
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.